Edward Abadir

Dr. Edward Abadir is a Senior Lecturer at the Central Clinical School within the Sydney Medical School at the University of Sydney. His research focuses on immunology and hematological malignancies, particularly investigating therapeutic targets such as CD300f, CD83, and CD302 in leukemia and lymphoma. He explores mechanisms underlying immune responses in diseases like multiple myeloma and acute myeloid leukemia, emphasizing T-cell subsets and hematopoietic stem cell transplantation efficacy. Collaborations include studies on measurable residual disease detection via flow cytometry and the role of CD16+ myeloid cells.

His work spans from basic immunology to translational research, addressing challenges in cancer immunotherapy and stem cell transplantation. Notable contributions include defining CD69- T-cell subsets in myeloma and evaluating CD300f as a therapeutic target in monocytic AML. His publications reflect a multidisciplinary approach integrating bioinformatics, flow cytometry, and clinical oncology.

No scientific awards or grants are explicitly listed in the provided information. He advises no students in the listed records, though collaborations with senior researchers suggest potential mentorship roles. His research is conducted within the Sydney Medical School’s clinical and translational research framework.